semaglutide for type 1 GLP-1s GLP-1 Drugs and Type 1

This is a low, introductory dose aimed at helping patients acclimate to the medication

Nature 625 , 92100 (2024)

contraindicated in patients with personal/family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2) Pancreatitis (acute inflammation presenting with severe abdominal pain) Gallbladder disease (cholecystitis or cholelithiasis) Acute kidney injury (risk increases with severe gastrointestinal adverse events causing dehydration) Diabetic retinopathy complications (for Ozempic

This dual action reducing calorie intake while potentially increasing calorie burn creates an ideal environment for weight loss

What are the main differences between Semaglutide and other GLP-1R agonists